Clinical trial
Sublingual Cockroach Safety in Adults With Cockroach Allergy & Perennial…
NCT00434421 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00434421 |
|---|---|
| Title | Sublingual Cockroach Safety in Adults With Cockroach Allergy & Perennial Allergic Rhinitis With or Without Asthma |
| Official title | A Safety and Pilot Dosing Study for Sublingual-Oral Administration of Glycerinated German Cockroach Allergenic Extract in Pediatric and Adult Subjects With Cockroach Allergy and Perennial Allergic Rhinitis With or Without Asthma |
| Acronym | SCSS |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Collaborators | Inner-City Asthma Consortium |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Allergy, Asthma |
| Intervention type | Drug |
| Interventions | Glycerinated German cockroach allergenic extract, Placebo |
| Enrollment | 28 |
| Start date | Feb 1, 2007 |
| Primary completion | Aug 1, 2009 |
| Completion | Aug 1, 2009 |
| First posted | Feb 13, 2007 |
| Last update posted | Jun 11, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: